PubMed

Diabetic nephropathy: diagnosis, prevention, and treatment.

Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T.

Diabetes Care. 2005 Jan;28(1):164-76. Review.PMID: 15616252 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of microalbuminuria in patients with type 2 diabetes mellitus.

Jerums G, MacIsaac RJ.

Treat Endocrinol. 2002;1(3):163-73. Review.PMID: 15799209 [PubMed - indexed for MEDLINE]Related articles

Diabetic nephropathy.

Zelmanovitz T, Gerchman F, Balthazar AP, Thomazelli FC, Matos JD, Canani LH.

Diabetol Metab Syndr. 2009 Sep 21;1(1):10.PMID: 19825147 [PubMed - in process]Related articlesFree article

Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.

Mogensen CE.

J Intern Med. 2003 Jul;254(1):45-66. Review.PMID: 12823642 [PubMed - indexed for MEDLINE]Related articles

[Microalbuminuria in diabetes mellitus--illness or symptom?]

Müller WA.

Versicherungsmedizin. 1996 Jun 1;48(3):70-6. Review. German. PMID: 8737541 [PubMed - indexed for MEDLINE]Related articles

Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.

Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H.

Diabetes Care. 2005 Nov;28(11):2728-32.PMID: 16249547 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical and therapeutic aspects of diabetic nephropathy.

Strippoli GF, Di Paolo S, Cincione R, Di Palma AM, Teutonico A, Grandaliano G, Schena FP, Gesualdo L.

J Nephrol. 2003 Jul-Aug;16(4):487-99. Review.PMID: 14696750 [PubMed - indexed for MEDLINE]Related articles

Albuminuria: a target for treatment of type 2 diabetic nephropathy.

de Zeeuw D.

Semin Nephrol. 2007 Mar;27(2):172-81. Review.PMID: 17418686 [PubMed - indexed for MEDLINE]Related articles

Drug treatment for hypertensive patients in special situations: diabetes and hypertension.

Mogensen CE.

Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):895-906. Review.PMID: 10423111 [PubMed - indexed for MEDLINE]Related articles

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.PMID: 16095545 [PubMed - indexed for MEDLINE]Related articlesFree article

[Diabetic nephropathy and cardiac disease]

Gross JL, Silveiro SP, Canani LH, Friedman R, Leitão CB, Azevedo MJ.

Arq Bras Endocrinol Metabol. 2007 Mar;51(2):244-56. Review. Portuguese. PMID: 17505631 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study.

Böger CA, Haak T, Götz AK, Christ J, Ruff E, Hoffmann U, Riegger GA, Krämer BK.

Int J Clin Pharmacol Ther. 2006 Aug;44(8):364-74.PMID: 16961167 [PubMed - indexed for MEDLINE]Related articles

[What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?]

Dussol B, Berland Y.

Nephrol Ther. 2006 May;2(2):51-74. Epub 2006 Mar 9. Review. French. PMID: 16895717 [PubMed - indexed for MEDLINE]Related articles

Benefits and cost of antihypertensive treatment in incipient and overt diabetic nephropathy.

Parving HH.

J Hypertens Suppl. 1998 Jan;16(1):S99-101. Review.PMID: 9534107 [PubMed - indexed for MEDLINE]Related articles

Blood pressure lowering for the prevention and treatment of diabetic kidney disease.

Thomas MC, Atkins RC.

Drugs. 2006;66(17):2213-34. Review.PMID: 17137404 [PubMed - indexed for MEDLINE]Related articles

Urinary albumin excretion is correlated to fibrinogen levels and protein S activity in patients with type 1 diabetes mellitus without overt diabetic nephropathy.

Lengyel Z, Vörös P, Tóth LK, Németh C, Kammerer L, Mihály M, Tornóci L, Rosivall L.

Wien Klin Wochenschr. 2004 Apr 30;116(7-8):240-5.PMID: 15143863 [PubMed - indexed for MEDLINE]Related articles

Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?

Herrera-Pombo JL, Aguilar-Diosdado M, Hawkins F, Campos MM, Moreno A, Garcia-Hernandez A, Castro E, García-Doncel LG, Serraclara A, Sánchez-Malo C, Escobar-Jiménez F.

Nephron Clin Pract. 2005;101(3):c116-21. Epub 2005 Jul 5.PMID: 16015000 [PubMed - indexed for MEDLINE]Related articles

Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment.

Ayodele OE, Alebiosu CO, Salako BL.

J Natl Med Assoc. 2004 Nov;96(11):1445-54. Review.PMID: 15586648 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.

Wang QY, Chen FQ.

Diabetes Res Clin Pract. 2009 Feb;83(2):215-9. Epub 2008 Dec 20.PMID: 19097668 [PubMed - indexed for MEDLINE]Related articles

Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria.

Nakamura T, Ushiyama C, Suzuki S, Shimada N, Sekizuka K, Ebihara L, Koide H.

Diabet Med. 2001 Apr;18(4):308-13.PMID: 11437862 [PubMed - indexed for MEDLINE]Related articles